SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 515 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,531,391 | +103721.7% | 106,205 | -5.9% | 0.04% | +15.6% |
| Q2 2023 | $21,702 | +133.9% | 112,845 | +146.1% | 0.03% | +113.3% |
| Q1 2023 | $9,279 | +73.1% | 45,853 | +9.9% | 0.02% | +87.5% |
| Q4 2022 | $5,359 | -99.9% | 41,723 | +35.8% | 0.01% | +14.3% |
| Q3 2022 | $4,203,000 | -24.1% | 30,729 | -1.8% | 0.01% | -30.0% |
| Q2 2022 | $5,534,000 | +28.4% | 31,284 | +4.6% | 0.01% | +42.9% |
| Q1 2022 | $4,310,000 | +1.5% | 29,918 | +9.0% | 0.01% | +16.7% |
| Q4 2021 | $4,245,000 | +36.6% | 27,454 | +50.0% | 0.01% | +20.0% |
| Q3 2021 | $3,107,000 | -80.7% | 18,299 | -82.0% | 0.01% | -80.0% |
| Q2 2021 | $16,074,000 | +560.4% | 101,815 | +480.8% | 0.02% | +525.0% |
| Q1 2021 | $2,434,000 | -40.6% | 17,530 | -25.1% | 0.00% | -50.0% |
| Q4 2020 | $4,099,000 | – | 23,405 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |